Bristol Myers Squibb: Perbedaan antara revisi

Bristol Myers Squibb
	Sebuah fasilitas riset dan pengembangan milik Bristol Myers Squibb di Lawrence, New Jersey
Jenis	Publik
Kode emiten	NYSE: BMY; Komponen S&P 100; Komponen S&P 500
Industri	Farmasi
Didirikan	1887; 137 tahun lalu
Pendiri	William McLaren Bristol ; John Ripley Myers ; E. R. Squibb
Kantor pusat	430 East 29th Street; New York City, New York, Amerika Serikat
Tokoh kunci	Giovanni Caforio, M.D.; (Chairman & CEO); Charles Bancroft; (CFO)
Pendapatan	US$42,518 milyar (2020)
Laba operasi	US$30,745 milyar (2020)
Laba bersih	▲ US$8,995 milyar (2020)
Total aset	US$129,44 milyar (2019)
Total ekuitas	US$59,70 milyar (2019)
Karyawan	30.000 (2019)
Situs web	BMS.com

Jelajahi riwayat secara interaktif

← Revisi sebelumnya

Konten dihapus Konten ditambahkan

VisualTeks wiki

Sebaris

Revisi terkini sejak 30 Januari 2023 00.53

Bristol Myers Squibb (BMS) adalah sebuah perusahaan farmasi yang berkantor pusat di New York City.^[3]

Bristol Myers Squibb memproduksi obat resep untuk sejumlah area terapeutik, seperti kanker, HIV/AIDS, penyakit kardiovaskular, diabetes, hepatitis, rheumatoid arthritis, dan gangguan jiwa.

Fasilitas riset dan pengembangan utama BMS terletak di Lawrence, New Jersey (sebelumnya milik Squibb, di dekat Princeton), New Brunswick, New Jersey, dan Redwood City, California; dengan fasilitas lain di Devens dan Cambridge, Massachusetts, East Syracuse, New York, Braine-l'Alleud, Belgia, Tokyo, Jepang, Bangalore, India, dan Wirral, Britania Raya.^[4]^[5] BMS juga pernah memiliki fasilitas riset dan pengembangan di Wallingford, Connecticut (sebelumnya milik Bristol-Myers).^[6]

Sejarah

Squibb

Squibb Corporation didirikan pada tahun 1858 oleh Edward Robinson Squibb di Brooklyn, New York.^[7]^[8] Squibb dikenal sebagai pendukung pengendalian kualitas dan standar kemurnian tinggi di masa-masa awal industri farmasi.^[9] Ia pun menerbitkan sendiri alternatif dari U.S. Pharmacopeia yang ia beri nama Squibb's Ephemeris of Materia Medica, setelah gagal meyakinkan American Medical Association untuk menerapkan standar kemurnian yang lebih tinggi.^[10] Materia Medica, produk Squibb, dan opini Edward Squibb mengenai dasar-dasar farmasi pun banyak ditemukan di artikel jurnal kesehatan pada akhir abad 1800-an.^[11]^[12]^[13]^[14] American Journal of Pharmacy pun menerbitkan lebih dari seratus artikel mengenai riset Squibb di industri farmasi.^[15]

Squibb Corporation kemudian menjadi pemasok besar barang-barang medis ke Tentara Uni selama Perang Saudara Amerika, dengan menyediakan peralatan medis portabel yang berisi morfin, anestesi bedah, dan kuinin untuk mengobati malaria (yang menjadi endemi di sebagian besar bagian timur Amerika Serikat pada saat itu).^[16]^[17]

Pada tahun 1944, Squibb membuka pabrik penisilin terbesar di dunia, di New Brunswick, New Jersey.^[18]

Bristol-Myers

Pada tahun 1887, lulusan Hamilton College, William McLaren Bristol dan John Ripley Myers membeli Clinton Pharmaceutical asal Clinton, New York.^[19] Pada bulan Mei 1898, mereka memutuskan untuk mengubah nama perusahaannya menjadi Bristol, Myers and Company.^[19] Pasca kematian Myers pada tahun 1899, Bristol mengubah nama perusahaannya menjadi Bristol-Myers Corporation.^[19] Selama dekade 1890-an, Bristol-Myers memperkenalkan produk populer pertamanya, yakni Sal Hepatica, sebuah garam mineral laksatif, dan kemudian diikuti oleh peluncuran pasta gigi Ipana pada tahun 1901.^[20]^[21] Divisi dari Bristol-Myers adalah Clairol (produk pewarna rambut dan perawatan rambut) serta Drackett (produk rumah tangga seperti Windex dan Drano).^[22]

Pada tahun 1943, Bristol-Myers mengakuisisi Cheplin Biological Laboratories, sebuah produsen susu acidophilus asal East Syracuse, New York,^[23] dan lalu mengubah pabrik milik Cheplin agar dapat memproduksi penisilin untuk Pasukan Sekutu Perang Dunia II.^[24] Pasca perang, pada tahun 1945, Bristol-Myers mengubah nama pabrik tersebut menjadi Bristol Laboratories dan masuk ke pasar antibiotik sipil, sehingga berkompetisi langsung dengan Squibb.^[20] Produksi penisilin di pabrik East Syracuse akhirnya dihentikan pada tahun 2005, karena sudah lebih murah jika diproduksi di luar Amerika Serikat.^[25]^[26] Hingga tahun 2010, pabrik tersebut digunakan untuk pengembangan proses manufaktur dan produksi obat biologis lain untuk tujuan uji klinis maupun komersial.^[27]^[28]

Penggabungan

Pada tahun 1989, Bristol-Myers dan Squibb resmi bergabung untuk membentuk Bristol-Myers Squibb.^[29]

Pada tahun 1999, Presiden Amerika Serikat, Bill Clinton memberi National Medal of Technology kepada Bristol-Myers Squibb, penghargaan tertinggi untuk pencapaian teknologi di Amerika Serikat, "karena telah memperpanjang dan meningkatkan kehidupan manusia melalui riset dan pengembangan farmasi inovatif, serta karena telah mendefinisikan ulang ilmu studi klinis melalui uji klinis yang kompleks dan baru, yang diakui sebagai percontohan di industrinya."^[30]

2000 - 2010

Logo Bristol-Myers Squibb dari tahun 1996 hingga 2020.

Pada tahun 2002, perusahaan ini terlibat dalam sebuah tuntutan mengenai monopoli secara ilegal terhadap Taxol, obat kanker buatannya, dan lima tahun kemudian kembali dituntut atas tuduhan antitrust, sehingga perusahaan ini harus mengeluarkan uang damai sebesar $125 juta.^[31]

Pada tahun 2002 juga, Bristol-Myers Squibb terlibat dalam sebuah skandal akuntansi yang menyebabkan perubahan pendapatannya dari tahun 1999 hingga 2001.^[32] Perubahan tersebut adalah hasil dari pencatatan penjualan yang tidak layak terkait "channel stuffing", yakni menjual stok berlebih ke distributor untuk menciptakan angka penjualan yang lebih tinggi.^[32] Perusahaan ini akhirnya berdamai dengan Departemen Kehakiman Amerika Serikat dan Komisi Sekuritas dan Bursa Amerika Serikat setelah setuju untuk membayar $150 juta.^[33]

Pada tanggal 24 Oktober 2002, Bristol-Myers Squibb Co. menurunkan pendapatannya untuk tahun 2000 dan 2001, serta menaikkan pendapatannya untuk tahun 2002 karena kekacauan stok besar-besaran yang kemudian mendorong penyelidikan dari pemerintah.^[34] Pada tanggal 15 Maret 2004, Bristol-Myers Squibb Co. menaikkan pendapatannya untuk kuartal keempat dan pendapatan tahunan untuk tahun 2003, setelah merevisi keputusan mereka sebelumnya mengenai cara untuk menangani kesalahan akuntansi di masa lalu.^[35] Sebagai bagian dari Perjanjian Penangguhan Penuntutan, perusahaan ini diawasi oleh tim yang ditunjuk oleh Jaksa Tinggi New Jersey. Selain itu, mantan kepala divisi farmasi, Richard Lane, dan mantan direktur keuangan perusahaan ini, Fred Schiff, pun didakwa atas pelanggaran keamanan federal.^[36]

Catatan dan referensi

^ ^a ^b ^c "Bristol Myers Squibb 2020 Full-Year Financial Results" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 5 February 2021.
^ ^a ^b ^c "Bristol Myers Squibb 2019 Annual Report" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 23 February 2020.
^ "Bristol-Myers Squibb - Contact Us". March 18, 2020.
^ "Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park" (Siaran pers). Diarsipkan dari versi asli tanggal 29 September 2012. Diakses tanggal 16 May 2012.
^ https://www.bms.com/about-us/our-company/worldwide-facilities/our-research-facilities.html
^ "Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure". Fiercepharma.com. Diakses tanggal 3 February 2019.
^ Gray, Christopher (2012-08-30). "Still in Fashion, a Century Later". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-20.
^ Kumar, B. (2012-11-14). Mega Mergers and Acquisitions: Case Studies from Key Industries (dalam bahasa Inggris). Springer. ISBN 978-1-137-00590-8.
^ The National Druggist (dalam bahasa Inggris). 1905.
^ "E. R. Squibb | American chemist". Encyclopedia Britannica (dalam bahasa Inggris). Diakses tanggal 2020-03-20.
^ Hollopeter, W.C. (January 8, 1885). "Inverse Type of Temperature in Typhoid Fever, with a Report of Two Cases — Temperature Peculiarities in Epidemics, with a Report of Seven Cases in One Family". Boston Medical and Surgical Journal. 112: 28–32. doi:10.1056/NEJM188308301090903. Diakses tanggal 2014-11-25. The writer noticed (in December, 1882) the important fact that when common or Japan camphor and crystallized carbolic acid are mixed together and subjected to heat, a colorless liquid would be the result. The only reference he finds so far with regard to this reaction occurs in the very excellent and valuable scientific publication of Dr. E. R. Squibb, " Ephemeris of Materia Medica", etc., on page 673, vol. ii., No. 5, where a brief allusion appears under the appellation of Compound Alum Powder. Dr. F. R. Squibb, however, in a letter to the writer states that he has " several times before heard of this reaction between phenol and camphor.
^ Worthen, Dennis (2003). "Edward Robinson Squibb (1819–1900): Advocate of Product Standards". Journal of the American Pharmacists Association. 46 (6): 754–758. doi:10.1331/1544-3191.46.6.754.Worthen. PMID 17176693. Diarsipkan dari versi asli tanggal 18 April 2014. Diakses tanggal 25 November 2014.
^ Blake, J.B. (1899). "Administration of Ether at the Boston City Hospital". Boston Med Surg J. 141 (13): 312–314. doi:10.1056/NEJM189909281411303. Until within six months Squibb's other has been exclusively used at the Boston City Hospital. Recently .MeliiHTéift's ether has been tried, ¡uni has given fair satisfaction ; Squibb's is still preferred by most of the house officers.
^ Brown, W.S. (1885). "Forty Year's Experience in Midwifery". Boston Medical and Surgical Journal. 112 (11): 241. doi:10.1056/nejm188503121121101. One reason why ergot has fallen into disrepute is the poor quality of many specimens offered for sale. Dr. Squibb's aqueous extract rarely disappoints me.
^ Capace, Nancy (2001-01-01). Encyclopedia of Delaware (dalam bahasa Inggris). Somerset Publishers, Inc. ISBN 978-0-403-09612-1.
^ Smith (2001). Medicines for the Union Army: the United States Army laboratories during the Civil War. Pharmaceutical Products Press. Accessed 2014-11-25.
^ Navy Medicine (dalam bahasa Inggris). Naval Medical Command. 2005.
^ Rosenbloom, Bert (2012-07-25). Marketing Channels (dalam bahasa Jerman). Cengage Learning. ISBN 978-1-133-70757-8.
^ ^a ^b ^c Cox, Jim (2008-09-18). Sold on Radio: Advertisers in the Golden Age of Broadcasting (dalam bahasa Inggris). McFarland. ISBN 978-0-7864-5176-0.
^ ^a ^b Bert Rosenbloom, Marketing Channels, Bristol-Myers Squibb, 2011, page 609
^ "Ipana toothpaste tasted success in early 1900s". Loveland Reporter-Herald (dalam bahasa Inggris). 2017-04-20. Diakses tanggal 2020-03-26.
^ Salpukas, Agis (1984-08-16). "BUSINESS PEOPLE; 3 Executive Changes Set by Bristol-Myers". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-26.
^ Botti, Timothy J. (2006). Envy of the World: A History of the U.S. Economy & Big Business (dalam bahasa Inggris). Algora Publishing. ISBN 978-0-87586-432-7.
^ "Bristol-Myers Squibb marks completion of East Syracuse plant's transformation". syracuse (dalam bahasa Inggris). 2013-09-13. Diakses tanggal 2020-07-09.
^ "Bristol-Myers Squibb: Big Pharma's small wonder". Fortune (dalam bahasa Inggris). Diakses tanggal 2019-12-10.
^ Harris, Gardiner (2009-01-19). "Drug Making's Move Abroad Stirs Concerns". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-26.
^ "At Bristol-Myers Squibb plant in East Syracuse, old buildings will make way for new drugs". syracuse (dalam bahasa Inggris). 2010-06-30. Diakses tanggal 2020-04-28.
^ "Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility - Pharmaceutical Technology". www.pharmaceutical-technology.com. Diakses tanggal 2020-04-28.
^ "Bristol-Myers, Squibb Agree to Merge : $12-Billion Stock Swap Would Form 2nd-Largest Drug Firm". Los Angeles Times (dalam bahasa Inggris). 1989-07-28. Diakses tanggal 2020-03-26.
^ "NSTMF". NSTMF. Diakses tanggal 2020-03-26.
^ "Bristol hit with antitrust suit". CNN. June 4, 2002. Diakses tanggal Jul 10, 2013.
^ ^a ^b Chopra, Prem (2009). Masters of the Game (dalam bahasa Inggris). Brook of Life. ISBN 978-0-9786321-3-7.
^ "Bristol-Myers Squibb Company : Lit. Rel. No. 18822" (Siaran pers). US Securities and Exchange Commission. August 6, 2004. Diakses tanggal May 9, 2015. Bristol-Myers inflated its results primarily by: (1) stuffing its distribution channels with excess inventory near the end of every quarter in amounts sufficient to meet sales and earnings targets set by officers ("channel-stuffing")
^ "Bristol-Myers to restate earnings as third quarter profits plunge". Diarsipkan dari versi asli tanggal 2013-11-05.
^ "Bristol-Myers restates results upward due to accounting errors". Diarsipkan dari versi asli tanggal 2015-09-24.
^ Saul, Stephanie (2005-06-15). "2 Former Bristol-Myers Executives Charged With Fraud". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-07-09.

Pranala luar

Bristol-Myers Squibb worldwide locations Diarsipkan 2017-05-08 di Wayback Machine.

Data bisnis Bristol-Myers Squibb:

[bm2k20-1] "Bristol Myers Squibb 2020 Full-Year Financial Results" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 5 February 2021.

[bm2k19-2] "Bristol Myers Squibb 2019 Annual Report" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 23 February 2020.

[3] "Bristol-Myers Squibb - Contact Us". March 18, 2020.

[4] "Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park" (Siaran pers). Diarsipkan dari versi asli tanggal 29 September 2012. Diakses tanggal 16 May 2012.

[5] ttps://www.bms.com/about-us/our-company/worldwide-facilities/our-research-facilities.html

[6] "Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure". Fiercepharma.com. Diakses tanggal 3 February 2019.

[7] Gray, Christopher (2012-08-30). "Still in Fashion, a Century Later". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-20.

[8] Kumar, B. (2012-11-14). Mega Mergers and Acquisitions: Case Studies from Key Industries (dalam bahasa Inggris). Springer. ISBN 978-1-137-00590-8.

[9] The National Druggist (dalam bahasa Inggris). 1905.

[10] "E. R. Squibb | American chemist". Encyclopedia Britannica (dalam bahasa Inggris). Diakses tanggal 2020-03-20.

[11] Hollopeter, W.C. (January 8, 1885). "Inverse Type of Temperature in Typhoid Fever, with a Report of Two Cases — Temperature Peculiarities in Epidemics, with a Report of Seven Cases in One Family". Boston Medical and Surgical Journal. 112: 28–32. doi:10.1056/NEJM188308301090903. Diakses tanggal 2014-11-25. The writer noticed (in December, 1882) the important fact that when common or Japan camphor and crystallized carbolic acid are mixed together and subjected to heat, a colorless liquid would be the result. The only reference he finds so far with regard to this reaction occurs in the very excellent and valuable scientific publication of Dr. E. R. Squibb, " Ephemeris of Materia Medica", etc., on page 673, vol. ii., No. 5, where a brief allusion appears under the appellation of Compound Alum Powder. Dr. F. R. Squibb, however, in a letter to the writer states that he has " several times before heard of this reaction between phenol and camphor.

[12] Worthen, Dennis (2003). "Edward Robinson Squibb (1819–1900): Advocate of Product Standards". Journal of the American Pharmacists Association. 46 (6): 754–758. doi:10.1331/1544-3191.46.6.754.Worthen. PMID 17176693. Diarsipkan dari versi asli tanggal 18 April 2014. Diakses tanggal 25 November 2014.

[13] Blake, J.B. (1899). "Administration of Ether at the Boston City Hospital". Boston Med Surg J. 141 (13): 312–314. doi:10.1056/NEJM189909281411303. Until within six months Squibb's other has been exclusively used at the Boston City Hospital. Recently .MeliiHTéift's ether has been tried, ¡uni has given fair satisfaction ; Squibb's is still preferred by most of the house officers.

[14] Brown, W.S. (1885). "Forty Year's Experience in Midwifery". Boston Medical and Surgical Journal. 112 (11): 241. doi:10.1056/nejm188503121121101. One reason why ergot has fallen into disrepute is the poor quality of many specimens offered for sale. Dr. Squibb's aqueous extract rarely disappoints me.

[15] Capace, Nancy (2001-01-01). Encyclopedia of Delaware (dalam bahasa Inggris). Somerset Publishers, Inc. ISBN 978-0-403-09612-1.

[16] Smith (2001). Medicines for the Union Army: the United States Army laboratories during the Civil War. Pharmaceutical Products Press. Accessed 2014-11-25.

[17] Navy Medicine (dalam bahasa Inggris). Naval Medical Command. 2005.

[18] Rosenbloom, Bert (2012-07-25). Marketing Channels (dalam bahasa Jerman). Cengage Learning. ISBN 978-1-133-70757-8.

[:7-19] Cox, Jim (2008-09-18). Sold on Radio: Advertisers in the Golden Age of Broadcasting (dalam bahasa Inggris). McFarland. ISBN 978-0-7864-5176-0.

[MarketingChannels-20] Bert Rosenbloom, Marketing Channels, Bristol-Myers Squibb, 2011, page 609

[21] "Ipana toothpaste tasted success in early 1900s". Loveland Reporter-Herald (dalam bahasa Inggris). 2017-04-20. Diakses tanggal 2020-03-26.

[22] Salpukas, Agis (1984-08-16). "BUSINESS PEOPLE; 3 Executive Changes Set by Bristol-Myers". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-26.

[23] Botti, Timothy J. (2006). Envy of the World: A History of the U.S. Economy & Big Business (dalam bahasa Inggris). Algora Publishing. ISBN 978-0-87586-432-7.

[24] "Bristol-Myers Squibb marks completion of East Syracuse plant's transformation". syracuse (dalam bahasa Inggris). 2013-09-13. Diakses tanggal 2020-07-09.

[25] "Bristol-Myers Squibb: Big Pharma's small wonder". Fortune (dalam bahasa Inggris). Diakses tanggal 2019-12-10.

[26] Harris, Gardiner (2009-01-19). "Drug Making's Move Abroad Stirs Concerns". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-03-26.

[27] "At Bristol-Myers Squibb plant in East Syracuse, old buildings will make way for new drugs". syracuse (dalam bahasa Inggris). 2010-06-30. Diakses tanggal 2020-04-28.

[28] "Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility - Pharmaceutical Technology". www.pharmaceutical-technology.com. Diakses tanggal 2020-04-28.

[29] "Bristol-Myers, Squibb Agree to Merge : $12-Billion Stock Swap Would Form 2nd-Largest Drug Firm". Los Angeles Times (dalam bahasa Inggris). 1989-07-28. Diakses tanggal 2020-03-26.

[30] "NSTMF". NSTMF. Diakses tanggal 2020-03-26.

[31] "Bristol hit with antitrust suit". CNN. June 4, 2002. Diakses tanggal Jul 10, 2013.

[:8-32] Chopra, Prem (2009). Masters of the Game (dalam bahasa Inggris). Brook of Life. ISBN 978-0-9786321-3-7.

[33] "Bristol-Myers Squibb Company : Lit. Rel. No. 18822" (Siaran pers). US Securities and Exchange Commission. August 6, 2004. Diakses tanggal May 9, 2015. Bristol-Myers inflated its results primarily by: (1) stuffing its distribution channels with excess inventory near the end of every quarter in amounts sufficient to meet sales and earnings targets set by officers ("channel-stuffing")

[34] "Bristol-Myers to restate earnings as third quarter profits plunge". Diarsipkan dari versi asli tanggal 2013-11-05.

[35] "Bristol-Myers restates results upward due to accounting errors". Diarsipkan dari versi asli tanggal 2015-09-24.

[36] Saul, Stephanie (2005-06-15). "2 Former Bristol-Myers Executives Charged With Fraud". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-07-09.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

@@ Baris 1: / Baris 1: @@
+{{short description|Perusahaan farmasi asal Amerika}}
-{{Kotak info perusahaan
-|company_name 		= Bristol-Myers Squibb Company
+{{About|perusahaan farmasi|rumah sakit anak di New Jersey|The Bristol-Myers Squibb Children's Hospital}}
+{{Infobox company
-|company_logo 		= [[Berkas:Bristol-Myers Squibb logo.svg|200px]]
+| name = Bristol Myers Squibb
-|caption 			=
+| logo = Bristol-Myers Squibb logo (2020).svg
-|company_type 		= publik ({{nyse|BMY}})
+| image = Bristolmyersprincetonfacility.jpg
-|genre 				=
+| image_size = 250px
-|foundation 		=
+| image_caption = Sebuah fasilitas riset dan pengembangan milik Bristol Myers Squibb di [[Lawrence Township, Mercer County, New Jersey|Lawrence]], [[New Jersey]]
-|founder 			=
+| type = [[Perusahaan publik|Publik]]
-|location_city 		= [[New York City]], [[New York]]
+| traded_as = {{NYSE|BMY}}<br>Komponen [[S&P 100]]<br>Komponen [[S&P 500]]
-|location_country 	= Amerika Serikat
+| industry = [[Farmasi]]
-|area_served 		= Seluruh dunia
+| founders = [[William McLaren Bristol]] <br/> [[John Ripley Myers]] <br/> [[E. R. Squibb]]
-|key_people 		= [[Lamberto Andreotti]]<br /><small>([[CEO]])</small>
+| foundation = {{Start date and age|1887}}
-|industry 			= farmasi
+| location = 430 East 29th Street<br>[[New York City]], [[New York]], Amerika Serikat
-|products 			=
+| key_people = {{nowrap|Giovanni Caforio, M.D.}}<br>{{nowrap|([[Chairman#Perusahaan publik|Chairman]] & [[CEO]])}}<br>{{nowrap|Charles Bancroft}}<br>{{nowrap|([[CFO]])}}
-|revenue          	= $16.385 juta
+| revenue = {{increase}} {{US$|42.518 milyar}} {{small|(2020)<ref name="bm2k20">{{cite web|url=https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2020/BMY-Q42020-Earnings-Press-Release.pdf |title=Bristol Myers Squibb 2020 Full-Year Financial Results |date=5 February 2021 |publisher=Bristol Myers Squibb |website=s21.q4cdn.com}}</ref>}}
-|operating_income 	=
+| operating_income = {{increase}} {{US$|30.745 milyar}} {{small|(2020)<ref name="bm2k20" />}}
-|net_income       	=
+| net_income = {{increasenegative}} US${{color|red|8,995 milyar}}  {{small|(2020)<ref name="bm2k20" />}}
-|assets           	= $38.592 juta
+| assets = {{increase}} {{US$}}129,44 milyar {{small|(2019)<ref name="bm2k19">{{cite web|url=https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/2019/2019-BMS-Annual-Report.pdf |title=Bristol Myers Squibb 2019 Annual Report |date=23 February 2020 |publisher=Bristol Myers Squibb |website=s21.q4cdn.com}}</ref>}}
-|equity           	=
+| equity = {{increase}} {{US$}}59,70 milyar {{small|(2019)}}<ref name="bm2k19" />
-|num_employees    	=
+| num_employees = {{increase}} 30.000 {{small|(2019)}}<ref name="bm2k19" />
-|owner 				=
+| homepage = {{url|https://www.bms.com|BMS.com}}
-|num_employees 		=
-|parent 			=
-|divisions 			=
-|company_slogan 	=
-|homepage 			= [http://www.bms.com www.bms.com]
-|dissolved 			=
-|footnotes 			=
 }}
-'''Bristol-Myers Squibb Company''' ({{nyse|BMY}}) adalah sebuah perusahaan publik asal [[Amerika Serikat]] yang bergerak di industri [[farmasi]].<ref name="fortune500">[http://fortune.com/fortune500/ ''Fortune 500 2015''. ''fortune.com''. Diakses 13 Januari 2015]</ref> Saat ini, markas pusat Bristol-Myers Squibb Company terletak di 345 Park Ave., [[New York City]], [[New York]], dan dipimpin oleh CEO [[Lamberto Andreotti]].<ref name="fortune500" />
+'''Bristol Myers Squibb''' ('''BMS''') adalah sebuah [[perusahaan farmasi]] yang berkantor pusat di [[New York City]].<ref>{{cite web|url=https://www.bms.com/about-us/contact-us.html|title=Bristol-Myers Squibb - Contact Us|date=March 18, 2020}}</ref>
+Bristol Myers Squibb memproduksi obat resep untuk sejumlah area terapeutik, seperti [[kanker]], [[HIV/AIDS]], [[penyakit kardiovaskular]], [[diabetes]], [[hepatitis]], [[rheumatoid arthritis]], dan [[gangguan jiwa]].
-Pada tahun 2013, Bristol-Myers Squibb Company masuk dalam daftar [[Fortune 500]], sebuah daftar peringkat perusahaan berdasarkan pendapatan kotornya yang dibuat oleh majalah [[Fortune]] setiap tahun.<ref name="fortune500" /> Bristol-Myers Squibb Company berada dalam peringkat 176 (sebelumnya peringkat 158) dengan pendapatan sekitar $16.385 juta, keuntungan sebesar $2.563 juta, dan total aset sebesar $38.592 juta.<ref name="fortune500" />
+Fasilitas riset dan pengembangan utama BMS terletak di [[Lawrence Township, Mercer County, New Jersey|Lawrence, New Jersey]] (sebelumnya milik Squibb, di dekat [[Princeton, New Jersey|Princeton]]), [[New Brunswick, New Jersey]], dan [[Redwood City, California]]; dengan fasilitas lain di [[Devens, Massachusetts|Devens]] dan [[Cambridge, Massachusetts]], [[East Syracuse, New York]], [[Braine-l'Alleud|Braine-l'Alleud, Belgia]], [[Tokyo|Tokyo, Jepang]], [[Bangalore|Bangalore, India]], dan [[Metropolitan Borough of Wirral|Wirral, Britania Raya]].<ref>{{cite press release |title=Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park |url=http://www.bmsi.co.in/bbrc.aspx?section=2 |access-date=May 16, 2012 |url-status=dead |archive-url=https://web.archive.org/web/20120929024338/http://www.bmsi.co.in/bbrc.aspx?section=2|archive-date=29 September 2012|df=dmy-all}}</ref><ref>https://www.bms.com/about-us/our-company/worldwide-facilities/our-research-facilities.html</ref> BMS juga pernah memiliki fasilitas riset dan pengembangan di [[Wallingford, Connecticut]] (sebelumnya milik Bristol-Myers).<ref>{{cite web |title=Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure |url=https://www.fiercepharma.com/pharma/bristol-myers-squibb-to-lay-off-149-as-wallingford-site-nears-closure |publisher=Fiercepharma.com |access-date=3 February 2019}}</ref>
-Bristol-Myers Squibb Company fokus pada penelitian, pengembangan, pelisensian, manufaktur, pemasaran, dan penjualan obat-obatan dan biofarmasi.<ref name="profil">[http://fortune.com/company/BMY/ Profil perusahaan Bristol-Myers Squibb Company di situs Fortune 500]</ref>
-== Referensi ==
+==Sejarah==
+===Squibb===
-{{reflist}}
+{{expand section|date=Januari 2020}}
+[[Image:E.R. Squibb & Son, Northern Blvd., Long Island City. LOC gsc.5a14902.jpg|thumb|left|Fasilitas milik E.R. Squibb & Son di Long Island City, New York, pada tahun 1948]]
+Squibb Corporation didirikan pada tahun 1858 oleh [[Edward Robinson Squibb]] di [[Brooklyn, New York|Brooklyn]], New York.<ref>{{Cite news|last=Gray|first=Christopher|url=https://www.nytimes.com/2012/09/02/realestate/brooklyn-heights-streetscapes-still-in-fashion-a-century-later.html|title=Still in Fashion, a Century Later|date=2012-08-30|work=The New York Times|access-date=2020-03-20|language=en-US|issn=0362-4331}}</ref><ref>{{Cite book|last=Kumar|first=B.|url=https://books.google.com/books?id=0lAjalmgNBUC&q=squibb+corporation+%221858%22&pg=PA54|title=Mega Mergers and Acquisitions: Case Studies from Key Industries|date=2012-11-14|publisher=Springer|isbn=978-1-137-00590-8|language=en}}</ref> Squibb dikenal sebagai pendukung pengendalian kualitas dan standar kemurnian tinggi di masa-masa awal industri farmasi.<ref>{{Cite book|url=https://books.google.com/books?id=nNgtGmY7iYIC&q=Squibb+was+known+as+an+advocate+of+quality+control+and+high+purity+standards&pg=PA192|title=The National Druggist|date=1905|language=en}}</ref> Ia pun menerbitkan sendiri alternatif dari [[United States Pharmacopeia|U.S. Pharmacopeia]] yang ia beri nama ''Squibb's Ephemeris of Materia Medica,'' setelah gagal meyakinkan [[American Medical Association]] untuk menerapkan standar kemurnian yang lebih tinggi.<ref>{{Cite web|url=https://www.britannica.com/biography/E-R-Squibb|title=E. R. Squibb {{!}} American chemist|website=Encyclopedia Britannica|language=en|access-date=2020-03-20}}</ref> ''Materia Medica'', produk Squibb, dan opini Edward Squibb mengenai dasar-dasar farmasi pun banyak ditemukan di artikel jurnal kesehatan pada akhir abad 1800-an.<ref>{{cite journal |title=Inverse Type of Temperature in Typhoid Fever, with a Report of Two Cases — Temperature Peculiarities in Epidemics, with a Report of Seven Cases in One Family |journal=Boston Medical and Surgical Journal |date=January 8, 1885 |last=Hollopeter |first=W.C. |volume=112 |pages=28–32 |doi=10.1056/NEJM188308301090903 |url=http://www.nejm.org/doi/full/10.1056/NEJM188710271171706 |access-date=2014-11-25 |quote="The writer noticed (in December, 1882) the important fact that when common or Japan camphor and crystallized carbolic acid are mixed together and subjected to heat, a colorless liquid would be the result. The only reference he finds so far with regard to this reaction occurs in the very excellent and valuable scientific publication of Dr. E. R. Squibb, " Ephemeris of Materia Medica", etc., on page 673, vol. ii., No. 5, where a brief allusion appears under the appellation of Compound Alum Powder. Dr. F. R. Squibb, however, in a letter to the writer states that he has " several times before heard of this reaction between phenol and camphor." }}</ref><ref>{{cite journal |title=Edward Robinson Squibb (1819–1900): Advocate of Product Standards |journal=Journal of the American Pharmacists Association |year=2003 |last=Worthen |first=Dennis |volume=46 |issue=6 |pages=754–758 |doi=10.1331/1544-3191.46.6.754.Worthen |pmid=17176693 |url=http://japha.org/article.aspx?articleid=1042039|access-date=2014-11-25 |archive-url=https://web.archive.org/web/20140418052223/http://japha.org/article.aspx?articleid=1042039 |archive-date=18 April 2014 |url-status=dead |df=dmy-all }}</ref><ref>{{cite journal|last=Blake|first=J.B.|year=1899|title=Administration of Ether at the Boston City Hospital|url=https://zenodo.org/record/1916260|journal=Boston Med Surg J|volume=141|issue=13|pages=312–314|doi=10.1056/NEJM189909281411303|quote="Until within six months Squibb's other has been exclusively used at the Boston City Hospital. Recently .MeliiHTéift's ether has been tried, ¡uni has given fair satisfaction ; Squibb's is still preferred by most of the house officers."}}<!--|access-date=2014-11-26 --></ref><ref>{{cite journal|last=Brown|first=W.S.|year=1885|title=Forty Year's Experience in Midwifery|url=https://zenodo.org/record/1429884|journal=Boston Medical and Surgical Journal|volume=112|issue=11|page=241|doi=10.1056/nejm188503121121101|quote="One reason why ergot has fallen into disrepute is the poor quality of many specimens offered for sale. Dr. Squibb's aqueous extract rarely disappoints me."}}<!--|access-date=2014-11-25 --></ref> ''[[American Journal of Pharmaceutical Education|American Journal of Pharmacy]]'' pun menerbitkan lebih dari seratus artikel mengenai riset Squibb di industri farmasi.<ref>{{Cite book|last=Capace|first=Nancy|url=https://books.google.com/books?id=u9StYwbI_F8C&q=U.S.+Pharmacopeia+Squibb%27s+Ephemeris+of+Materia+Medica&pg=PA227|title=Encyclopedia of Delaware|date=2001-01-01|publisher=Somerset Publishers, Inc.|isbn=978-0-403-09612-1|language=en}}</ref>
+Squibb Corporation kemudian menjadi pemasok besar barang-barang medis ke Tentara Uni selama [[Perang Saudara Amerika]], dengan menyediakan [[peralatan medis]] portabel yang berisi [[morfin]], anestesi bedah, dan [[kuinin]] untuk mengobati malaria (yang menjadi endemi di sebagian besar bagian timur Amerika Serikat pada saat itu).<ref>{{cite book |last=Smith |title= Medicines for the Union Army: the United States Army laboratories during the Civil War|url=https://archive.org/details/medicinesforunio00smit |url-access=registration |publisher= Pharmaceutical Products Press|year= 2001}} Accessed 2014-11-25.</ref><ref>{{Cite book|url=https://books.google.com/books?id=ueAJxIW6gu0C&q=Bristol-Myers+Squibb+union+army&pg=RA3-PA24|title=Navy Medicine|date=2005|publisher=Naval Medical Command|language=en}}</ref>
-== Lihat pula ==
-* [[Fortune 500]]
-* [[New York Stock Exchange]]
-* [[Perusahaan publik]]
+Pada tahun 1944, Squibb membuka pabrik penisilin terbesar di dunia, di [[New Brunswick, New Jersey]].<ref>{{Cite book|last=Rosenbloom|first=Bert|url=https://books.google.com/books?id=6WMJAAAAQBAJ&q=1944&pg=PA609|title=Marketing Channels|date=2012-07-25|publisher=Cengage Learning|isbn=978-1-133-70757-8|language=de}}</ref>
-== Pranala luar ==
+{{clear}}
-* [http://www.bms.com Situs resmi Bristol-Myers Squibb Company]
-{{perusahaan-stub}}
+===Bristol-Myers===
+{{expand section|date=Januari 2020}}
+[[File:Sal Hepatica by Bristol Myers Co (1909).jpg|thumb|right|100px|Sal Hepatica (1909)]]
+Pada tahun 1887, lulusan [[Hamilton College (New York)|Hamilton College]], [[William McLaren Bristol]] dan [[John Ripley Myers]] membeli Clinton Pharmaceutical asal [[Clinton, Oneida County, New York|Clinton]], New York.<ref name=":7">{{Cite book|last=Cox|first=Jim|url=https://books.google.com/books?id=RwVkMMLqMdkC&q=In+1887%2C+Hamilton+College+graduates+William+McLaren+Bristol+and+John+Ripley+Myers+purchased+the+Clinton+Pharmaceutical+company+of+Clinton%2C+New+York&pg=PA95|title=Sold on Radio: Advertisers in the Golden Age of Broadcasting|date=2008-09-18|publisher=McFarland|isbn=978-0-7864-5176-0|language=en}}</ref> Pada bulan Mei 1898, mereka memutuskan untuk mengubah nama perusahaannya menjadi '''Bristol, Myers and Company'''.<ref name=":7" /> Pasca kematian Myers pada tahun 1899, Bristol mengubah nama perusahaannya menjadi '''Bristol-Myers Corporation'''.<ref name=":7" /> Selama dekade 1890-an, Bristol-Myers memperkenalkan produk populer pertamanya, yakni [[Sal Hepatica]], sebuah garam mineral [[laksatif]], dan kemudian diikuti oleh peluncuran pasta gigi [[Ipana]] pada tahun 1901.<ref name="MarketingChannels">Bert Rosenbloom, ''Marketing Channels'', [https://books.google.com/books?id=6WMJAAAAQBAJ&pg=PA609 Bristol-Myers Squibb], 2011, page 609</ref><ref>{{Cite web|url=https://www.reporterherald.com/ci_30933687/ipana-toothpaste-tasted-success-early-1900s|title=Ipana toothpaste tasted success in early 1900s|date=2017-04-20|website=Loveland Reporter-Herald|language=en-US|access-date=2020-03-26}}</ref> Divisi dari Bristol-Myers adalah Clairol (produk pewarna rambut dan perawatan rambut) serta Drackett (produk rumah tangga seperti Windex dan Drano).<ref>{{Cite news|last=Salpukas|first=Agis|url=https://www.nytimes.com/1984/08/16/business/business-people-3-executive-changes-set-by-bristol-myers.html|title=BUSINESS PEOPLE; 3 Executive Changes Set by Bristol-Myers|date=1984-08-16|work=The New York Times|access-date=2020-03-26|language=en-US|issn=0362-4331}}</ref>
+Pada tahun 1943, Bristol-Myers mengakuisisi Cheplin Biological Laboratories, sebuah produsen susu ''[[acidophilus]]'' asal [[East Syracuse, New York]],<ref>{{Cite book|last=Botti|first=Timothy J.|url=https://books.google.com/books?id=4UPo0V1qovwC&q=Squibb+world%27s+largest+penicillin+plant+for+army&pg=PA250|title=Envy of the World: A History of the U.S. Economy & Big Business|date=2006|publisher=Algora Publishing|isbn=978-0-87586-432-7|language=en}}</ref> dan lalu mengubah pabrik milik Cheplin agar dapat memproduksi [[penisilin]] untuk Pasukan [[Sekutu Perang Dunia II]].<ref>{{Cite web|date=2013-09-13|title=Bristol-Myers Squibb marks completion of East Syracuse plant's transformation|url=https://www.syracuse.com/news/2013/09/bristol-myers_squibb_marks_completion_of_east_syracuse_plants_transformation.html|access-date=2020-07-09|website=syracuse|language=en}}</ref> Pasca perang, pada tahun 1945, Bristol-Myers mengubah nama pabrik tersebut menjadi [[Bristol Laboratories]] dan masuk ke pasar [[antibiotik]] sipil, sehingga berkompetisi langsung dengan Squibb.<ref name="MarketingChannels"/> Produksi penisilin di pabrik East Syracuse akhirnya dihentikan pada tahun 2005, karena sudah lebih murah jika diproduksi di luar Amerika Serikat.<ref>{{Cite web|url=https://fortune.com/2014/06/02/fortune-500-bristol-myers/|title=Bristol-Myers Squibb: Big Pharma's small wonder|website=Fortune|language=en|access-date=2019-12-10}}</ref><ref>{{Cite news|last=Harris|first=Gardiner|url=https://www.nytimes.com/2009/01/20/health/policy/20drug.html|title=Drug Making's Move Abroad Stirs Concerns|date=2009-01-19|work=The New York Times|access-date=2020-03-26|language=en-US|issn=0362-4331}}</ref> Hingga tahun 2010, pabrik tersebut digunakan untuk pengembangan proses manufaktur dan produksi [[biofarmasi|obat biologis]] lain untuk tujuan uji klinis maupun komersial.<ref>{{Cite web|url=https://www.syracuse.com/news/2010/06/at_bristol-myeres_squibb_plant.html|title=At Bristol-Myers Squibb plant in East Syracuse, old buildings will make way for new drugs|date=2010-06-30|website=syracuse|language=en|access-date=2020-04-28}}</ref><ref>{{Cite web|url=https://www.pharmaceutical-technology.com/projects/bristolmyerseastsyra/|title=Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility - Pharmaceutical Technology|website=www.pharmaceutical-technology.com|access-date=2020-04-28}}</ref>
+{{clear}}
+===Penggabungan===
+Pada tahun 1989, Bristol-Myers dan Squibb resmi bergabung untuk membentuk Bristol-Myers Squibb.<ref>{{Cite web|url=https://www.latimes.com/archives/la-xpm-1989-07-28-fi-295-story.html|title=Bristol-Myers, Squibb Agree to Merge : $12-Billion Stock Swap Would Form 2nd-Largest Drug Firm|date=1989-07-28|website=Los Angeles Times|language=en-US|access-date=2020-03-26}}</ref>
+Pada tahun 1999, Presiden Amerika Serikat, [[Bill Clinton]] memberi [[National Medal of Technology]] kepada Bristol-Myers Squibb, penghargaan tertinggi untuk pencapaian teknologi di Amerika Serikat, "karena telah memperpanjang dan meningkatkan kehidupan manusia melalui riset dan pengembangan farmasi inovatif, serta karena telah mendefinisikan ulang ilmu studi klinis melalui uji klinis yang kompleks dan baru, yang diakui sebagai percontohan di industrinya."<ref>{{Cite web|url=https://www.nationalmedals.org/laureates/bristol-myers-squibb-company|title=NSTMF|website=NSTMF|access-date=2020-03-26}}</ref>
+===2000 - 2010===
+[[File:Bristol-Myers Squibb Logo.svg|right|thumb|Logo Bristol-Myers Squibb dari tahun 1996 hingga 2020.]]
+[[Image:Bristol-Myers Squibb building at 100 Nassau Park Boulevard 2010.jpg|thumb|left|Perusahaan ini memiliki sejumlah fasilitas di New Jersey. Salah satunya yang terletak di perbatasan West Windsor dan Princeton ini]]
+Pada tahun 2002, perusahaan ini terlibat dalam sebuah tuntutan mengenai monopoli secara ilegal terhadap Taxol, obat kanker buatannya, dan lima tahun kemudian kembali dituntut atas tuduhan [[antitrust]], sehingga perusahaan ini harus mengeluarkan uang damai sebesar $125 juta.<ref>{{cite news |url=https://money.cnn.com/2002/06/04/news/companies/bristol |title= Bristol hit with antitrust suit |date=June 4, 2002 |access-date=Jul 10, 2013 |work=CNN}}</ref>
+Pada tahun 2002 juga, Bristol-Myers Squibb terlibat dalam sebuah [[skandal akuntansi]] yang menyebabkan perubahan pendapatannya dari tahun 1999 hingga 2001.<ref name=":8">{{Cite book|last=Chopra|first=Prem|url=https://books.google.com/books?id=Np3htQTKG10C&q=2002%2C+Bristol-Myers+Squibb+was+involved+in+an+accounting+scandal+that+resulted+in+a+significant+restatement+of+revenues+from+1999+to+2001&pg=PA327|title=Masters of the Game|date=2009|publisher=Brook of Life|isbn=978-0-9786321-3-7|language=en}}</ref> Perubahan tersebut adalah hasil dari pencatatan penjualan yang tidak layak terkait "[[channel stuffing]]", yakni menjual stok berlebih ke distributor untuk menciptakan angka penjualan yang lebih tinggi.<ref name=":8" /> Perusahaan ini akhirnya berdamai dengan [[Departemen Kehakiman Amerika Serikat]] dan [[Komisi Sekuritas dan Bursa Amerika Serikat]] setelah setuju untuk membayar $150 juta.<ref>{{cite press release|url=https://www.sec.gov/litigation/litreleases/lr18822.htm |title= Bristol-Myers Squibb Company : Lit. Rel. No. 18822 |publisher=US Securities and Exchange Commission |access-date= May 9, 2015 |date= August 6, 2004 |quote= Bristol-Myers inflated its results primarily by: (1) stuffing its distribution channels with excess inventory near the end of every quarter in amounts sufficient to meet sales and earnings targets set by officers ("channel-stuffing") }}</ref>
+Pada tanggal 24 Oktober 2002, Bristol-Myers Squibb Co. menurunkan pendapatannya untuk tahun 2000 dan 2001, serta menaikkan pendapatannya untuk tahun 2002 karena kekacauan stok besar-besaran yang kemudian mendorong penyelidikan dari pemerintah.<ref>{{cite web |url=http://www.highbeam.com/doc/1P1-68980061.html |archive-url=https://web.archive.org/web/20131105214250/http://www.highbeam.com/doc/1P1-68980061.html |url-status=dead |archive-date=2013-11-05 |title= Bristol-Myers to restate earnings as third quarter profits plunge}}</ref> Pada tanggal 15 Maret 2004, Bristol-Myers Squibb Co. menaikkan pendapatannya untuk kuartal keempat dan pendapatan tahunan untuk tahun 2003, setelah merevisi keputusan mereka sebelumnya mengenai cara untuk menangani kesalahan akuntansi di masa lalu.<ref>{{cite web |url=http://www.highbeam.com/doc/1P1-92165333.html |archive-url=https://web.archive.org/web/20150924182701/http://www.highbeam.com/doc/1P1-92165333.html |url-status=dead |archive-date=2015-09-24 |title= Bristol-Myers restates results upward due to accounting errors}}</ref> Sebagai bagian dari Perjanjian Penangguhan Penuntutan, perusahaan ini diawasi oleh tim yang ditunjuk oleh Jaksa Tinggi [[New Jersey]]. Selain itu, mantan kepala divisi farmasi, Richard Lane, dan mantan direktur keuangan perusahaan ini, Fred Schiff, pun didakwa atas pelanggaran keamanan federal.<ref>{{Cite news|last=Saul|first=Stephanie|date=2005-06-15|title=2 Former Bristol-Myers Executives Charged With Fraud|language=en-US|work=The New York Times|url=https://www.nytimes.com/2005/06/15/business/2-former-bristolmyers-executives-charged-with-fraud.html|access-date=2020-07-09|issn=0362-4331}}</ref>
+== Catatan dan referensi ==
+{{reflist|30em}}
+==Pranala luar==
+{{Commons category}}
+* [https://www.bms.com/about-us/our-company/worldwide-facilities.html#westwindsor Bristol-Myers Squibb worldwide locations] {{Webarchive|url=https://web.archive.org/web/20170508081411/https://www.bms.com/about-us/our-company/worldwide-facilities.html#westwindsor |date=2017-05-08 }}
+{{Finance links
+| name = Bristol-Myers Squibb
+| symbol = BMY
+| sec_cik = BMY
+| yahoo = BMY
+| google = BMY
+}}
+{{Perusahaan farmasi Amerika Serikat}}
+{{Authority control}}
 [[Kategori:Perusahaan Amerika Serikat]]

Pengawasan otoritas
Umum	ISNI 1 VIAF 1 WorldCat (via VIAF)
Perpustakaan nasional	Prancis (data) Amerika Serikat Republik Ceko 2 3
Lain-lain	Microsoft Academic SUDOC (Prancis) 1